costar logo

CO-STAR

A randomised feasibility study Comparing UroLift and Standard Transurethral resection of prostate Ahead of Radiotherapy in men with urinary symptoms secondary to prostate enlargement.

What is CO-STAR?

A detailed outline of the study's purpose, plus information on participating centres and other useful resources.

Who is involved?

A complete list of the researchers behind the CO-STAR study.

Key dates and study progress

The CO-STAR trial is anticipated to begin in November 2022, with results due in September 2024.

Contact us

You can get in touch with us by calling 020 7352 8171, or emailing CO-STAR@rmh.nhs.uk.

logo
logo
logo
logo
logo
logo
logo
logo